Implications of Matched Adjusted Indirect Treatment Comparisons in Rare Disease
June 2, 2021
Open to all ISPOR Members and Non-members
Presented by:
- Shirley Liao
- Crystal M. Proud
June 2, 2021
1:00PM EDT | 6:00PM BST | 7:00PM CEST
Click here for time zone conversion
A one-hour educational webinar on the implications of matched adjusted indirect treatment comparisons in rare disease, using SMA as an example. Webinar will provide both statistical and clinical perspective.
Learning Objectives:
- Quantitatively illustrate how results of matched adjusted indirect comparisons can be influenced by confounding factors using example from infantile-onset SMA
- Understand importance and implications of well-conducted indirect treatment comparisons for clinical practice in rare disease.
Sponsored by: Biogen
Presenters:
Shirley Liao, PhD, Senior Biostatistician, Biogen, Cambridge, MA, USA
Crystal M. Proud, MD, Pediatric Neuromuscular Neurologist, Children’s Hospital of The King’s Daughters, Norfolk, VA, USA
Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later
date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 weeks after the scheduled Webinar.
Reservations are on a first-come, first-served basis.
Reservations are on a first-come, first-served basis.